Australia's state of New South Wales (NSW) will invest more than 120 million Australian dollars (nearly $83 million) in biosecurity measures to help combat animal diseases, such as foot-and-mouth disease (FMD) and lumpy skin disease.
The state government announced on Monday that the investment will deliver 65 million Australian dollars (nearly $45 million) for the development of mRNA synthetic vaccines for both the FMD and lumpy skin disease, Xinhua news agency reported.
It will also include 55.8 million Australian dollars (nearly $38 million) for a response workforce, disease surveillance and on-ground biosecurity risk mitigation and preparedness activities, such as controlling potential infected premises and incentivising farmers to beef up their biosecurity measures.
Deputy Premier and Minister for Regional NSW, Paul Toole said current FMD vaccines are made using the virus itself, meaning if Australia wants to regain FMD-free status after an outbreak, some vaccinated animals still need to be destroyed .
"The development of a synthetic mRNA vaccine could be the key for Australia to apply for FMD-free status without having to destroy vaccinated animals."
"We need to be prepared to fight and eradicate any exotic pest and disease that arrives on our shores," said NSW Agriculture Minister Dugald Saunders.
"Our farmers deserve to have the confidence to know that if we have an outbreak of Foot and Mouth Disease."
The FMD, which attacks cloven-hoofed animals such as cattle, pigs, goats and sheep, has been detected in the neighbouring Indonesia, raising concerns that the highly contagious animal disease may spread to Australia for the first time in more than 130 years.
Australia has taken biosecurity measures, including deploying more biosecurity officers at airports and mail centers, risk-profiling 100 per cent of passengers arriving from Indonesia, and using sanitation foot mats in all international airports, in efforts to fend off the FMD.
--IANS
int/khz/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app